Company Number: 13216902

Analysis Date: 2025-07-29 16:28 UTC

1. Credit Opinion: DECLINE
   Herbal Service Ltd exhibits significant financial weakness with persistent net liabilities and negative shareholders' funds that have deteriorated over the last three years. The company’s inability to generate positive net current assets and ongoing losses reflected in accumulated reserves raise serious concerns about its capacity to meet current and future debt obligations. The absence of employees and limited tangible fixed assets further suggest minimal operational scale, increasing credit risk. Without clear evidence of improving profitability or equity injection, extending credit is not advisable.

2. Financial Strength:
   The company’s balance sheet shows net liabilities of £12,481 as of 31 March 2024, worsening from £9,051 the previous year. Current liabilities exceed current assets by £12,635, indicating a deficient working capital position. Fixed assets are minimal (£154 net book value), and there are no reported intangible or other significant assets. The negative revaluation reserve of £10,051 alongside a negative profit and loss reserve of £3,430 contributes to the weak equity base. Overall, the capital structure is fragile with no buffer to absorb losses or support growth.

3. Cash Flow Assessment:
   Cash holdings have decreased from £1,544 in 2023 to an implied lower level in 2024 (not explicitly stated but current assets are negative net of liabilities), reflecting strained liquidity. The company’s current liabilities of £12,635 are due within one year and likely require cash outflows that cannot be supported by current liquid assets. Absence of employees and operational scale suggests limited ongoing cash generation capacity. This weak liquidity position undermines confidence in the company’s ability to service short-term obligations.

4. Monitoring Points:

• Quarterly review of cash balances and current liabilities to detect liquidity stress.
• Updates on any capital injections or shareholder support to improve equity position.
• Profit and loss performance in upcoming trading periods to assess potential turnaround.
• Director commentary on business plan or restructuring efforts to improve financial health.
• Watch for any late filings or increasing creditor pressure that may signal worsening distress.